Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 4 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Recs

0
Player Avatar guinness4life (54.13) Submitted: 12/21/2011 6:21:56 PM : Outperform Start Price: $40.77 LLY Score: -5.15

Long this. Gorgeous value stock with great dividend. I got in a few months ago. Get in the next time a drug misses approval.

Featured Broker Partners


Advertisement